Targeting angiogenesis in oncology, ophthalmology and beyond
Targeting angiogenesis in oncology, ophthalmology and beyond
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Angiogenesis is an essential process in normal development and in adult physiology, but can be disrupted in numerous diseases. The concept of targeting angiogenesis for treating diseases was proposed more than 50 years ago, and the first two drugs targeting vascular endothelial growth factor (VEGF), bevacizumab and pegaptanib, were approved in 2004...
Alternative Titles
Full title
Targeting angiogenesis in oncology, ophthalmology and beyond
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_swepub_primary_oai_swepub_ki_se_446568
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_446568
Other Identifiers
ISSN
1474-1776
E-ISSN
1474-1784
DOI
10.1038/s41573-023-00671-z
